ロード中...

Thioredoxin reductase: A novel, independent prognostic marker in patients with hepatocellular carcinoma

Here we found that hepatocellular carcinoma (HCC) patients with recurrence outcome and nonsurvivors had significantly increased thioredoxin reductase (TrxR) serum levels on reoperation (P < 0.0001 and P < 0.0001). Multivariate regression analysis adjusted for common risk factors showed that Tr...

詳細記述

保存先:
書誌詳細
出版年:Oncotarget
主要な著者: Li, Chunyan, Peng, Yan, Mao, Binglang, Qian, Kun
フォーマット: Artigo
言語:Inglês
出版事項: Impact Journals LLC 2015
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4627346/
https://ncbi.nlm.nih.gov/pubmed/25970775
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!